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Background: Exercise has the potential to improve physical function and quality of life in individuals with bone
metastases but is often avoided due to safety concerns. This systematic review summarizes the safety, feasibility
and efficacy of exercise in controlled trials that include individuals with bone metastases.
Methods: MEDLINE, Embase, Pubmed, CINAHL, PEDro and CENTRAL databases were searched to July 16, 2020.
Results: A total of 17 trials were included incorporating aerobic exercise, resistance exercise or soccer in
terventions. Few (n = 4, 0.5%) serious adverse events were attributed to exercise participation, with none related
to bone metastases. Mixed efficacy results were found, with exercise eliciting positive changes or no change. The
majority of trials included an element of supervised exercise instruction (n = 16, 94%) and were delivered by
qualified exercise professionals (n = 13, 76%).
Conclusions: Exercise appears safe and feasible for individuals with bone metastases when it includes an element
of supervised exercise instruction.

1. Introduction
Preservation of physical function is a key objective of cancer reha
bilitation in patients with advanced cancer (Cheville et al., 2016; Padgett
et al., 2018). The presence of bone metastases can lead to abrupt and
clinically significant declines in physical function and overall perfor
mance status, which has been associated with increased healthcare uti
lization, reduced quality of life and fewer treatment options (Silver et al.,
2013; Kurtz et al., 2005; Ten Tusscher et al., 2019; Maltser et al., 2017).
Regular exercise (e.g. aerobic and resistance exercise) has been shown to
improve measures of physical function in cancer patients and is

recommended as an effective supportive care strategy (Campbell et al.,
2019; Hayes et al., 2019; Cormie et al., 2018; Support, 2018). However,
exercise is often underutilized by medical professionals for patients with
bone metastases due to uncertainties around safety and the overall risk of
skeletal-related events (SREs) associated with bone metastases, including
pathological fracture and spinal cord compression (Cheville et al., 2011;
Silver et al., 2018; Sheill et al., 2018a; Ten Tusscher et al., 2020). In
contrast, patients with bone metastases have expressed interest in
receiving exercise information and participating in exercise programs,
highlighting the need for evidence-informed guidance on exercise as a
therapeutic intervention in this setting (Ten Tusscher et al., 2019; Delrieu
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characteristics), safety (adverse events, exclusion criteria, exercise
modifications), feasibility (recruitment, attendance, study retention,
adherence), and efficacy outcomes (between group mean differences,
95% confidence intervals and p-values). Two reviewers (SW and NHH)
independently assessed risk of bias using Cochrane Risk of Bias 2.0 for
RCTs and Risk of Bias In Non-Randomized Studies of Interventions,
identifying “high risk”, “some concerns” and “low risk” of bias of each
trial (Sterne et al., 2019; Sterne et al., 2016). Disagreements were dis
cussed and resolved. Corresponding authors of included trials were
contacted when additional information was required.
Descriptive statistics including mean, standard deviation (SD) &
range were generated with SPSS v25 (IBM Corporation; Chicago, IL,
USA) to summarize data from eligible trials. A separate descriptive
analysis was conducted for trials that only included individuals with
bone metastases. For trials that included individuals with and without
bone metastases, results of the total sample are presented.

et al., 2019; Lowe et al., 2010; Sheill et al., 2018b).
Previous systematic reviews on exercise in people with advanced
cancer exist, yet to our knowledge, none have primarily focused on par
ticipants with bone metastases (Heywood et al., 2018; Nadler et al., 2019;
Beaton et al., 2009; Dittus et al., 2017; Lowe et al., 2009; Titz et al., 2016;
Salakari et al., 2015). A meta-analysis by Nadler et al. evaluating exercise
interventions in individuals with advanced cancer included a sub-group
analysis from six trials that included some participants with bone me
tastases and concluded that exercise was likely safe if it was supervised
and individually tailored (Nadler et al., 2019). The authors note that the
appropriateness and safety of unsupervised exercise is currently unclear
due to lack of randomized controlled trials (RCTs) that include partici
pants with bone metastases in exercise interventions (Nadler et al., 2019).
Given the risk of SREs associated with bone metastases and the
negative consequences elicited by poor physical function, it is important
to establish the safety and efficacy of exercise specific to individuals
with bone metastases across supervised and unsupervised settings
(Sturgeon et al., 2019; Coleman, 2006; Healey and Brown, 2000). To
effectively design and implement exercise within clinical settings, it is
also critical to understand exercise feasibility (El-Kotob and Gian
gregorio, 2018). To address this gap in the knowledgebase, we con
ducted a systematic review to summarize and qualitatively assess the
safety, feasibility and efficacy of exercise in controlled trials that include
individuals with bone metastases.

3. Results
3.1. Overview
A total of 12,781 records were identified through the database search
and 24 publications met the eligibility criteria, representing 17 trials
(eSupplement, eFig. 1). Of the excluded trials, 11 did not record the
number of participants who had bone metastases and were therefore
excluded. Of the included trials, one trial was a controlled clinical trial
(Rosenberger et al., 2017) and the remaining 16 were RCTs (Bjerre et al.,
2019a, b; Bourke et al., 2011, 2014; Cheville et al., 2019; Cormie et al.,
2013; Dawson et al., 2018; Galvão et al., 2018; Litterini et al., 2013; Rief
et al., 2014a, b, c, d, 2016; Scott et al., 2018; Solheim et al., 2017; Sprave
et al., 2019; Uster et al., 2018; Uth et al., 2014, 2016a, b; Villumsen
et al., 2019; Yee et al., 2019). Four (24%) trials included only partici
pants with bone metastases (Cormie et al., 2013; Galvão et al., 2018;
Rief et al., 2014a, b, c, d, 2016; Sprave et al., 2019), and the remaining
13 (76%) trials included participants with and without bone metastases.
A total of 1489 participants were included in our review, of which 645
(43%) had bone metastases and 845 (57%) were assigned to an exercise
intervention group. The mean (SD) participant age was 65 (5) years.
Trials recruited participants with prostate cancer (n = 8, 47%) (Bjerre
et al., 2019a, b; Bourke et al., 2011, 2014; Cormie et al., 2013; Dawson
et al., 2018; Galvão et al., 2018; Uth et al., 2014, 2016a, b; Villumsen
et al., 2019), breast cancer (n = 2, 12% (Scott et al., 2018, Yee et al.,
2019)) or mixed tumor types (n = 7, 41%) (Cheville et al., 2019; Litterini
et al., 2013; Rief et al., 2014a, b, c, d, 2016; Rosenberger et al., 2017;
Solheim et al., 2017; Sprave et al., 2019; Uster et al., 2018).
Five (29%) trials had a low risk of bias (Bjerre et al., 2019a, b;
Cheville et al., 2019; Dawson et al., 2018; Scott et al., 2018; Sprave et al.,
2019), ten (59%) had some concerns (Bourke et al., 2011, 2014; Cormie
et al., 2013; Galvão et al., 2018; Rosenberger et al., 2017; Solheim et al.,
2017; Uster et al., 2018; Uth et al., 2014, 2016a, b; Villumsen et al.,
2019; Yee et al., 2019), and two (13%) had a high risk of bias (Litterini
et al., 2013; Rief et al., 2014a, b, c, d, 2016) (Fig. 1). Risk of bias con
cerns were predominantly due to a lack of published trial protocol or
detailed trial registration (Bourke et al., 2011, 2014; Cormie et al., 2013;
Litterini et al., 2013; Solheim et al., 2017; Yee et al., 2019), absence of
appropriate analysis to measure between group effect (Galvão et al.,
2018; Rief et al., 2014a, b, c, d, 2016; Uster et al., 2018; Uth et al., 2014,
2016a, b; Villumsen et al., 2019), unequal dropout between study arms
that may have influenced results (Litterini et al., 2013; Rosenberger
et al., 2017), and selection bias of reported results across multiple
publications (Rief et al., 2014a, b, c, d, 2016).

2. Methods
2.1. Literature Search
Preferred Reporting Items for Systematic Reviews and Meta-analysis
(PRISMA) (Moher et al., 2009) reporting guidelines were followed and
registration with PROSPERO (CRD42019121958). Electronic databases
(MEDLINE, Embase, Pubmed, CINAHL, PEDro and CENTRAL) were
searched from inception to 16 July 2020, using a search strategy
developed in consultation with a university librarian. Additionally, grey
literature and reference lists of eligible papers were searched. The search
included subject headings or keywords for “cancer” and “bone metas
tases or advanced cancer” and “exercise” (eSupplement eTable 1). Limits
included human participants and publication in English.
2.2. Eligibility Criteria
Inclusion criteria were: 1) design: RCT or controlled clinical trial; 2)
population: 18-years or older with a diagnosis of cancer; sample included
participants with metastatic bone disease (with confirmed number of
participants with bone metastases); 3) intervention: any exercise inter
vention comprising more than one session of structured exercise; 4)
comparator group: usual care, control or comparator interventions; and
5) outcome: at least one outcome related to efficacy on physical function
(e.g., sit to stand), functional capacity (e.g., cardiopulmonary exercise
test), muscular strength (e.g., one repetition maximum) or treatment side
effect (e.g., fatigue). Exercise was operationally defined as aerobic,
resistance or flexibility exercise, sports-specific training (e.g., soccer),
yoga, tai chi, Pilates or a combination of any of these modalities. Struc
tured exercise refers to an exercise prescription given to be performed in
a supervised or unsupervised setting.
2.3. Trial Selection, Data Extraction and Synthesis
Citations yielded from the search were exported to Endnote (Clar
ivate Analytics, Philadelphia, PA) and duplicates were removed (Bramer
et al., 2016). Title and abstract screening was performed by two review
teams (SW and SM; KAB and NHH). Two reviewers (SW and NHH)
independently performed full-text screenings. Data was extracted using
a standard form that included sample and intervention characteristics
(age, presence of bone metastases, exercise prescription, supervision

3.2. Intervention Characteristics
The exercise intervention characteristics (i.e., frequency, intensity,
time, type, duration) of each trial are described in Table 1 (additional
2
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information eSupplement eTable 2). Overall, 14 (82%) trials prescribed
resistance exercise (resistance exercise only, n = 8; resistance and aer
obic exercise, n = 6), two trials prescribed aerobic exercise alone (Lit
terini et al., 2013; Scott et al., 2018) and two trials evaluated a soccer
intervention (Bjerre et al., 2019a, b; Uth et al., 2014, 2016). In studies
including resistance exercise, 12 (86%) trials prescribed whole body
resistance training (Bourke et al., 2011, 2014; Cheville et al., 2019;
Cormie et al., 2013; Dawson et al., 2018; Galvão et al., 2018; Litterini
et al., 2013; Rosenberger et al., 2017; Solheim et al., 2017; Uster et al.,
2018; Villumsen et al., 2019; Yee et al., 2019) and two (14%) trials
prescribed isometric spinal stabilization exercises with holds of 20-sec
onds or greater per exercise (Rief et al., 2014a, b, c, d, 2016; Sprave
et al., 2019). Comparator groups included usual care (n = 12, 71%),
attention control (n = 4, 24%) (Dawson et al., 2018; Rief et al., 2014a, b,
c, d, 2016; Scott et al., 2018; Sprave et al., 2019), or an alternate exercise
modality (e.g., resistance versus aerobic exercise) (n = 1, 6%) (Litterini
et al., 2013). Fifteen (88%) trials used moderate-to-vigorous intensity

aerobic and/or resistance exercise prescriptions.
Inclusion of at least one session of supervised exercise was a
component of all but one (93%) trial (Solheim et al., 2017). Nine (53%)
trials included only supervised exercise sessions (Bjerre et al., 2019a, b;
Cormie et al., 2013; Dawson et al., 2018; Galvão et al., 2018; Litterini
et al., 2013; Rosenberger et al., 2017; Scott et al., 2018; Uster et al.,
2018; Uth et al., 2014, 2016a,b), five (29%) trials included a combi
nation of supervised and unsupervised exercise (Bourke et al., 2011,
2014, Rief et al., 2014a, b, c, d, 2016; Sprave et al., 2019; Yee et al.,
2019), one (6%) trial included a single exercise demonstration session
followed by unsupervised exercise (Villumsen et al., 2019), one (6%)
trial included unsupervised exercise only with distanced-based tele
phone check ins and optional in-person physical therapy sessions
(Cheville et al., 2019) and one (6%) trial was entirely unsupervised
(Solheim et al., 2017). Overall, unsupervised exercise was included with
892 (60% of total) participants. Exercise supervision was predominantly
provided by qualified exercise professionals (n = 13, 76%) including

Fig. 1. Risk of Bias of included studies. 1a Risk of bias, all included trials, as percentage. 1b Risk of bias, individual trials.
3
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Table 1
Overview of included trials.
Source

Cancer Type

Sample/
MBD (%)

Intervention

Significant findings of exercise intervention (between-group)

Bjerre et al., 2019a, b

Prostate

Soccer vs UC

Improved mental health.

Bourke et al., 2011

Adv Prostate

214/41
(19%)
50/13 (25%)

AET, RT & Diet vs UC

Bourke et al., 2014

Adv Prostate

100/20
(20%)

AET, RT & Diet vs UC

Improved exercise tolerance, physical function, strength,
fatigue.
Improved QoL, exercise tolerance, fatigue.

Cheville et al., 2019

Mixed Adv

516/264
(51%)

(1a) AET & RT & PT vs (1b) +/- pain
management vs control

Cormie et al., 2013

Adv Prostate

RT vs UC

Improved physical function, strength, body composition.

Dawson et al., 2018

Prostate

RT vs control (stretch)

Improved QoL, strength, body composition.

Galvão et al., 2018

Adv Prostate

AET, RT & Flex vs UC

Improved physical function, strength.

Litterini et al., 2013
Rief et al., 2014a, b, c, d,
2016
Rosenberger et al., 2017
Scott et al., 2018

Mixed Adv

20/20
(100%)
35/13 (13%)
57/57
(100%)
66/16 (24%)

(1a) improved physical function, QoL, discharge time, LOS,
pain interference.
(1b) improved discharge home, pain interference.

AET vs RT

No change.

Mixed Adv

60/60 (!00%)

RT vs Control (breathing)

Improved physical function, body composition, pain score.

Mixed Adv
Adv Breast
Adv Lung &
Panc.

25/6 (24%)
65/17 (26%)

RT vs UC
AET vs Control (stretch)

Improved body composition, strength.
No change.

46/8 (17%)

AET & RT vs UC

Improved body composition.

RT vs Control (muscle relax)

No change.

AET, RT & Diet vs UC
Soccer vs UC
Exergaming vs UC
AET & RT vs UC

No change.
Improved body composition, strength.
Improved physical function.
Improved QoL, fatigue, physical function.

Solheim et al., 2017
Sprave et al., 2019

Mixed Adv

Uster et al., 2018
Uth et al., 2014, 2016a, b
Villumsen et al., 2019
Yee et al., 2019

Mixed Adv
Adv Prostate
Adv Prostate
Adv Breast

60/60
(100%)
58/14 (24%)
57/11 (19%)
46/16 (35%)
14/9 (62%)

Abbreviations: Adv = advanced; AET = aerobic exercise training; Flex = flexibility training; LOS = length of stay; Panc = Pancreatic; QoL = quality of life; RT =
resistance training; UC = usual care.

physical therapists/physiotherapists (n = 6, 35%) (Cheville et al., 2019;
Litterini et al., 2013; Rief et al., 2014a, b, c, d, 2016; Sprave et al., 2019;
Uster et al., 2018; Villumsen et al., 2019), clinical exercise physiologists
(n = 6, 35%) (Bourke et al., 2011, 2014; Cormie et al., 2013; Galvão
et al., 2018; Scott et al., 2018; Sprave et al., 2019) or other university
trained exercise professionals (e.g., kinesiologists or sports therapists) (n
= 3, 18%) (Litterini et al., 2013; Yee et al., 2019; Rosenberger et al.,
2017).

differences between the intervention and control groups at baseline
(23% vs 30%, p = 0.56) or end of intervention (23% vs 30%, p = 0.59%)
(Rief et al., 2014a, b, c, d, 2016).
Key to interpreting safety, criteria specific to inclusion and exclusion
of participants with bone metastases is outlined in Table 3. Nine trials
(53%) used exclusion criteria specific to bone metastases, namely
excluding individuals presenting with unstable bone metastases (n = 4,
24%) (Bourke et al., 2011, 2014, Rief et al., 2014a, b, c, d, 2016;
Rosenberger et al., 2017) or pain associated with the bone lesion (n = 7,
41%) (Bourke et al., 2011, 2014; Cormie et al., 2013; Galvão et al., 2018;
Uster et al., 2018; Uth et al., 2014, 2016a, b; Yee et al., 2019). Four
(24%) trials used inclusion criteria that required a physician clearance
(Bjerre et al., 2019a, b; Cormie et al., 2013; Dawson et al., 2018; Litterini
et al., 2013) and eight (47%) trials required a minimum performance
status that included ambulation and basic self-care (i.e., Eastern Coop
erative Oncology Group [ECOG] performance status 0 – 1/2; Karnofsky
performance status [KPS] >70) (Rief et al., 2014a, b, c, d, 2016; Rose
nberger et al., 2017; Scott et al., 2018; Solheim et al., 2017; Sprave et al.,
2019; Uster et al., 2018; Villumsen et al., 2019; Yee et al., 2019). Three
(18%) trials specifically included higher risk populations that presented
with pain related to the lesion site (Rief et al., 2014a, b, c, d, 2016),
functional impairments (Cheville et al., 2019) or unstable bone metas
tases (i.e., high fracture risk) (Sprave et al., 2019).
Exercise prescription modifications specific to bone metastases were
used in seven (41%) trials (eSupplement eTable 3) (Cheville et al., 2019;
Cormie et al., 2013; Dawson et al., 2018; Galvão et al., 2018; Litterini
et al., 2013; Rief et al., 2014a, b, c, d, 2016; Sprave et al., 2019). Three
(18%) trials in men with prostate cancer prescribed resistance exercises
that minimized loading to the lesion area (e.g., avoided horizontal press
exercises when lesion present in thoracic spine) (Dawson et al., 2018;
Cormie et al., 2013; Galvão et al., 2018). Four (24%) trials in individuals
with mixed tumor types used other exercise modification approaches (e.
g., using resistance bands instead of machines) (Cheville et al., 2019;
Litterini et al., 2013; Rief et al., 2014a, b, c, d, 2016; Sprave et al., 2019).
The remaining ten trials (59%) did not report exercise modifications
specific to bone-metastases and included soccer, resistance exercise and

3.3. Safety
All but one trial reported on adverse events (AEs) (Bourke et al.,
2011), with nine (53%) trials measuring AEs in both intervention and
comparator groups and seven (41%) trials measuring AEs in the inter
vention group only (Table 2). Seven (41%) trials reported use of a
comprehensive classification tool that specified AE grade and severity
(e.g., National Cancer Institute Common Terminology Criteria for
Adverse Events). Overall, three trials (18%) reported serious adverse
events (SAEs) associated with the trial and all included samples with and
without bone metastases (Bjerre et al., 2019a, b; Solheim et al., 2017;
Uth et al., 2014, 2016a, b). A total of 57 SAEs were reported in these
three trials; 27 SAEs occurred in intervention group participants and 30
SAEs occurred in control group participants. Only four SAEs (0.5% of
total exercise intervention participants) were attributed to an exercise
intervention, all of which were attributed to soccer and were not related
to bone metastases. One trial by Uth et al. reported three SAEs that
included two fibula fractures and one partial achilles tendon rupture
(Uth et al., 2014, 2016a, b). A second trial by Bjerre et al. reported 33
SAEs resulting in hospital admission, 11 in the intervention group and
22 in the usual care group, with one SAE attributed to the intervention,
which was a soft-tissue injury that was not related to bone metastases
(Bjerre et al., 2019a, b). Of note, in the four trials that exclusively
included individuals with bone metastases, no SAEs occurred during the
trials (Cormie et al., 2013; Galvão et al., 2018; Rief et al., 2014a, b, c, d,
2016; Sprave et al., 2019). Additionally, one trial reported specifically
on the presence of pathological fractures and found no significant
4
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Table 2
Safety considerations and outcomes of included studies
Source

AE
Reporting

AE Criteria

Total SAEs Reported (I/C)

Total AEs Reported (I/C)

Bjerre et al., 2019a, b
Bourke et al., 2011

GCP Guidelines
NA

33 (11/12) 1 related to exercisea
NA

Falls 26 (10/6) Fractures 3 (1/2) Injuries 60 (60/0)
NA

Bourke et al., 2014
Cheville et al., 2019

I&C
Not
Reported
I&C
I&C

None
None

0
0

Cormie et al., 2013

I&C

None. Incidence &
severity.

0

Dawson et al., 2018

I only

Galvão et al., 2018

I only

Litterini et al., 2013
Rief et al., 2014a, b, c,
d, 2016
Rosenberger et al., 2017

0
0

0

I only

NCI CTCAE v4.3
None. Incidence &
severity.
None

0
0
Increased bone pain 1 (1/0)
Adv disease 2 (1/1)
Fall (home) 1 (1/0)
0

0

0

I&C

GCP Guidelines

0

0

I only

None

0

Scott et al., 2018

I&C

MedDRA

0

Solheim et al., 2017
Sprave et al., 2019
Uster et al., 2018
Uth et al., 2014, 2016a,
b
Villumsen et al., 2019
Yee et al., 2019

I&C
I&C
I only

NCI CTCAE v3.0
NCI CTCAE v4.03
None

21 (13/8)None related to exercise
0
0
3 (3/NR) 3 related to exercisea [Fractured fibula = 2,
Partial Achilles rupture = 1]
0
0

Weakness, pain or injury 11 (11/NR)
73% of AET group had AE (e.g., abnormal HR
response, fatigue, back pain)
Grade 3 (e.g., pain, infection) 12 (7/5)
0
0

I only

None

I&C
I only

None
NCI CTCAE v4.0

Muscle strain 1 (1/NR)
Chest pain, non-heart related 1 (1/0)
0

a
Not related to bone metastases; Abbreviations: AE = adverse event; C = Control group; GCP = Good Clinical Practice; I = intervention group; NCI CTCAE =
National Cancer Institute Common Terminology Criteria for Adverse Events; NR = Not reported; SAE = serious adverse event.

Table 3
Participant inclusion and exclusion criteria of included trials
Bjerre et al., 2019a, b
Bourke et al., 2011
Bourke et al., 2014
Cheville et al., 2019
Cormie et al., 2013
Dawson et al., 2018
Galvão et al., 2018
Litterini et al., 2013
Rief et al., 2014a, b, c, d, 2016
Rosenberger et al., 2017
Scott et al., 2018
Solheim et al., 2017
Sprave et al., 2019
Uster et al., 2018
Uth et al., 2014, 2016a, b
Villumsen et al., 2019
Yee et al., 2019

Physician Clearance (n = 4)

Painful Metastases (n = 7)

Unstable Metastases (n = 4)

Function Impairment (n = 8)

Inclusion
X
X
X
Inclusion
Inclusion
X
Inclusion
X
X
X
X
X
X
X
X
X

X
Exclusion
Exclusion
X
Exclusion
X
Exclusion
X
Inclusion
X
X
X
X
Exclusion
Exclusion
X
Exclusion

X
Exclusion
Exclusion
X
X
X
X
X
Exclusion
Exclusion
X
X
Inclusion
X
X
X
X

X
X
X
Inclusion
X
X
X
X
KPS <70
ECOG >2
ECOG >1
KPS <70
KPS <70
ECOG >2
X
ECOG >2
ECOG >2

Abbreviations: X = criteria not used; Inclusion = Required for participant to be included in trial; Exclusion = If present, criteria excluded participant from trial.

aerobic exercise interventions (Bjerre et al., 2019a, b; Bourke et al.,
2011, 2014; Rosenberger et al., 2017; Scott et al., 2018; Solheim et al.,
2017; Uster et al., 2018; Uth et al., 2014, 2016a, b; Villumsen et al.,
2019; Yee et al., 2019).
3.4. Study Feasibility
Participant recruitment, attendance, study retention and adherence
are reported in Fig. 2 (additional information eSupplement eTable 4).
Overall, mean (SD) recruitment rate was 46(25)%, ranging from 12% to
93%. Trials exclusive to individuals with bone metastases reported mean
recruitment rates of 64(12)% compared to mixed trials of 40(26)%.
Mean attendance was 75(12)% across all trials, ranging from 59% to
100%, with supervised trials reporting attendance of 79(14)% and un
supervised trials 66(20)%. Trials exclusive to individuals with bone
metastases reported mean attendance rates of 79(12)% compared to
mixed trials 74(12)%. Mean retention was 83(10)% during the trial
period, ranging from 53% to 100%. Trials exclusive to individuals with

Fig. 2. Feasibility of all trials included in systematic review, mean (SD) %.

bone metastases reported mean retention rates of 74(14)% compared to
mixed trials of 86(7)%. Adherence to the exercise intervention was only
reported in eight trials, each measuring adherence differently, making it
difficult to report the exercise intensity and duration completed (Bjerre
et al., 2019a, b; Cormie et al., 2013; Dawson et al., 2018; Rosenberger
et al., 2017; Scott et al., 2018; Solheim et al., 2017; Villumsen et al.,
2019; Yee et al., 2019).
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3.5. Efficacy

UDoHaH, 2009).
Our findings support that the addition of unsupervised exercise for
individuals with bone metastases may be safe, provided an element of
supervised exercise instruction (i.e., individualized, in-person demon
stration and practice) is initially included or regular check-in opportu
nities with suitably qualified exercise professionals are provided. This is
somewhat contrary to the summary from Nadler et al. that suggested
only exercise in a supervised setting is safe (Nadler et al., 2019). In our
review, 47% of trials included an element of unsupervised exercise.
Inclusion of unsupervised exercise may improve access for individuals
who face barriers to supervised exercise sessions, such as difficulty
travelling due to functional impairments or immunocompromise, or lack
of access due to location or cost (Sheill et al., 2018b). For supervised
exercise, supervision was predominately provided by university-trained
exercise professionals including clinical exercise physiologists and
physical therapists/physiotherapists; consistent with the recently pub
lished clinical guidance recommending that people with cancer with
higher clinical needs should be referred to these highly qualified exer
cise professionals (Schmitz et al., 2019). These findings provide a
foundation for future research and clinical exercise programming for
individuals with bone metastases to explore different models of delivery
combined with qualified oversight (Cormie et al., 2018; Schmitz et al.,
2019; Body et al., 2016).
To safely translate these research findings into clinical practice,
understanding appropriate pre-exercise screening and exercise modifi
cations is required. All RCTs included in this review used screening
criteria that required either: 1) physician clearance prior to exercise; or
2) a minimum level of functioning that included ambulation and basic
self-care (e.g., ECOG 0-2 or KPS > 70); or 3) an absence of unstable bone
metastases or pain related to lesion(s). Other screening approaches have
been suggested in individuals with bone metastases to identify those at
risk of a SAE (i.e., Mirels and Taneichi scales) (Maltser et al., 2017;
Support, 2018; Nadler et al., 2019; Sheill et al., 2018c; Taneichi et al.,
1997; Mirels, 2003). However, only two studies in our review imple
mented these tools, suggesting more research is required to confirm their
utility for pre-exercise screening, especially for use in clinical practice
(Rief et al., 2014a, b, c, d, 2016; Sprave et al., 2019).
While the optimal exercise prescription for individuals with bone
metastases is currently undefined, our review found that exercise pre
scriptions predominantly fell within the levels recommended for in
dividuals living with and beyond cancer by the American College of
Sports Medicine (ACSM), including at least 90 minutes of moderate-tovigorous intensity aerobic exercise and two days a week of resistance
exercise (Campbell et al., 2019). The majority of trials (n = 14, 82%)
included resistance training, which aligns with the clinical focus to
preserve and increase physical function in individuals with bone me
tastases (Cheville et al., 2016; Padgett et al., 2018).
Moderate-to-vigorous exercise intensity was prescribed in the majority
of trials, highlighting the capacity of individuals with bone metastases to
perform increased exercise intensities that have been previously shown
to be efficacious for cancer survivors (Campbell et al., 2019; Hayes et al.,
2019).
Based on our findings, evidence on exercise modifications for in
dividuals with bone metastases currently appears mixed, with 10 (59%)
trials included in our review reporting no exercise modifications. Of
note, all studies that included higher risk individuals with functional
impairments, unstable metastases or bone pain used exercise modifica
tions and no SAEs were reported (Cheville et al., 2019; Rief et al., 2014a,
b, c, d, 2016; Sprave et al., 2019). More research and enhanced reporting
of exercise intervention adherence is required to better define exercise
recommendations, modifications and optimal exercise dose in in
dividuals presenting with bone metastases. Some of this work has
commenced to progress the evidence base for exercise effectiveness in
people with bone metastases or advanced cancers (of which many will
have bone metastases), including for cancer-specific endpoints such as
delays to symptomatic skeletal events and disease progression, and

Across all 17 trials, no significant negative effects of the exercise
intervention were reported in any efficacy outcome (Table 1, eSupple
ment eTable 2). A variety of patient reported outcomes and objective
test measures were used. A summary of the between-group efficacy re
sults of each trial is shown in eSupplement eFig. 2. Significant between
group improvement in physical function, fatigue and quality of life that
favour exercise was reported in seven (54%) trials (Bourke et al., 2011;
Cheville et al., 2019; Cormie et al., 2013; Galvão et al., 2018; Rief et al.,
2014a, b, c, d, 2016; Villumsen et al., 2019; Yee et al., 2019), three
(23%) trials (Bourke et al., 2011, 2014; Yee et al., 2019) and four (31%)
trials (Bourke et al., 2014; Cheville et al., 2019; Dawson et al., 2018; Yee
et al., 2019), respectively. Significant between group improvements in
body composition and objective measures of muscular strength that
favour exercise was reported in six (43%) trials (Cormie et al., 2013;
Dawson et al., 2018; Rief et al., 2014a, b, c, d, 2016; Rosenberger et al.,
2017; Solheim et al., 2017; Uth et al., 2014, 2016a, b) and six (67%)
trials (Bourke et al., 2011; Cormie et al., 2013; Dawson et al., 2018;
Galvão et al., 2018; Rosenberger et al., 2017; Uth et al., 2014, 2016a, b),
respectively. Finally, significant between group reductions in pain that
favour exercise was reported in two (29%) trials (Cheville et al., 2019;
Rief et al., 2014a, b, c, d, 2016).
In trials that exclusively included individuals with bone metastases
(n = 4), results were mixed and a range of test measures were used
(eSupplement eTable 2). Three (75%) trials (Cormie et al., 2013; Galvão
et al., 2018; Rief et al., 2014a, b, c, d, 2016) reported significant
between-group improvements in physical functioning that favour exer
cise and two (50%) trials (Cormie et al., 2013; Galvão et al., 2018) re
ported significant between-group improvements in muscle strength that
favour exercise. All trials measured pain (n = 4), with one (25%) trial
(Rief et al., 2014a, b, c, d, 2016) reporting a reduction in pain levels and
three (75%) trials (Cormie et al., 2013; Galvão et al., 2018; Sprave et al.,
2019) reporting no difference between groups. No significant between
group exercise effect was reported for fatigue (n = 4) or quality of life (n
= 3) (Cormie et al., 2013; Rief et al., 2014a, b, c, d 2016; Sprave et al.,
2019).
4. Discussion
This systematic review supports that exercise is feasible in in
dividuals with bone metastases and that participation in aerobic and
resistance exercise does not appear to result in SAEs related to exercise.
Soccer participation was associated with a small number of SAEs related
to exercise (n = 4), however, none of these were related to the presence
of bone metastases. Mixed efficacy results were found, with no negative
effects of exercise reported. Participation in structured exercise showed
an overall trend toward increasing physical function and muscular
strength across all trials (54%, 67% respectively) and in trials exclusive
to individuals with bone metastases (75%, 50% respectively).
Establishing the safety profile of exercise interventions for patients
with bone metastases is a key consideration to enable medical pro
fessionals to advise on exercise suitability (Sheill et al., 2018a; Silver
et al., 2015). The studies included in this systematic review reported no
SAEs in interventions prescribing aerobic and/or resistance exercise that
included at least one session of supervised exercise instruction. Partici
pation in aerobic and resistance exercise did not appear to increase the
rate of pathological fracture, pain or use of pain medication. The few
SAEs reported were attributed to soccer participation, and these were all
musculoskeletal injuries consistent with participation in a contact sport
(i.e., fibula fracture) with none occurring at known lesion sites. Overall,
our results suggest that in a controlled trial setting, the benefits of ex
ercise may outweigh perceived risks. Future research should include the
number, type and severity of each adverse event using pre-established
criteria (e.g., Common Terminology Criteria for Adverse Events) and
record AEs in both the intervention and control groups (Services
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improvements to progression-free and overall survival (Brown et al.,
2019; Hart et al., 2017, 2018; Newton et al., 2018). This work has been
made possible, in part, because of established safety and feasibility data
in the literature that we have systematically reported in this review.
Given the ability to explore the minimum effective dose, dose-response
relationships, and various physiological effects of exercise modalities,
intensities and volumes; it is now worthwhile for future research to
examine the use of wearable technology and telemedicine delivery of
exercise medicine to promote pragmatic randomised controlled trials
and implementation efforts beyond the exercise clinic, and into the
community setting (including people in rural and remote areas who are
often disadvantaged).
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